How do I buy BriaCell Therapeutics (BCTX) stock?

You can purchase shares of BriaCell Therapeutics (NASDAQ:BCTX) through any online brokerage.View our list of the best stock brokerages

Who are BriaCell Therapeutics (BCTX) competitors?

Other companies in BriaCell Therapeutics’s space includes: Serina Therapeutics Inc (AMEX:SER), Skye Bioscience Inc (NASDAQ:SKYE), Intensity Therapeutics Inc (NASDAQ:INTS), Lunai Bioworks Inc (NASDAQ:LNAI) and Nanoviricides Inc (AMEX:NNVC).

What is the forecast, or price target, for BriaCell Therapeutics (BCTX) stock?

BriaCell Therapeutics has a consensus price target of $40.00.

What is the current price for BriaCell Therapeutics (BCTX)?

The stock price for BriaCell Therapeutics (NASDAQ: BCTX) is $4.5 last updated January 22, 2026 at 7:14 PM EST.

Does BriaCell Therapeutics (BCTX) pay a dividend?

There are no upcoming dividends for BriaCell Therapeutics.

When is BriaCell Therapeutics (NASDAQ:BCTX) reporting earnings?

BriaCell Therapeutics does not have any upcoming earnings scheduled.

Is BriaCell Therapeutics (BCTX) going to split?

There is no upcoming split for BriaCell Therapeutics.

What sector and industry does BriaCell Therapeutics (BCTX) operate in?

BriaCell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BriaCell Therapeutics (BCTX) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherap...

Comments